KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Danaher (DHR) Research & Development (2016 - 2026)

Danaher has reported Research & Development over the past 17 years, most recently at $438.0 million for Q4 2025.

  • Quarterly results put Research & Development at $438.0 million for Q4 2025, down 0.9% from a year ago — trailing twelve months through Dec 2025 was $1.6 billion (up 0.88% YoY), and the annual figure for FY2025 was $1.6 billion, up 0.88%.
  • Research & Development for Q4 2025 was $438.0 million at Danaher, up from $378.0 million in the prior quarter.
  • Over the last five years, Research & Development for DHR hit a ceiling of $442.0 million in Q4 2024 and a floor of $236.0 million in Q4 2022.
  • Median Research & Development over the past 5 years was $387.0 million (2024), compared with a mean of $385.5 million.
  • Biggest five-year swings in Research & Development: plummeted 36.62% in 2021 and later surged 72.46% in 2023.
  • Danaher's Research & Development stood at $251.0 million in 2021, then fell by 5.98% to $236.0 million in 2022, then surged by 72.46% to $407.0 million in 2023, then increased by 8.6% to $442.0 million in 2024, then dropped by 0.9% to $438.0 million in 2025.
  • The last three reported values for Research & Development were $438.0 million (Q4 2025), $378.0 million (Q3 2025), and $403.0 million (Q2 2025) per Business Quant data.